Rick Klausner
North America, California, United States
Description
Rick Klausner is a Chief Executive Officer at Lyell Immunopharma.
Investor Profile
Rick Klausner has backed more than 4 startups, with 0 new investments in the last 12 months alone. The firm has led 3 rounds, about 75% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series B, Convertible Note rounds (top funding stages).
- Majority of deals are located in United Kingdom, United States, The Netherlands.
- Strong thematic focus on Biotechnology, Health Care, Commercial.
Stage Focus
- Series A (50%)
- Series B (25%)
- Convertible Note (25%)
Country Focus
- United Kingdom (25%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
- United States (25%)
- The Netherlands (25%)
- Israel (25%)
Industry Focus
- Biotechnology
- Health Care
- Commercial
- Genetics
- Life Science
- Therapeutics
- Food And Beverage
- Food Processing
- Innovation Management
- Apps
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Rick Klausner frequently co-invest with?
'/%3e%3cuse xlink:href='%23a' transform='rotate(144 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(216 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(288 450 300)'/%3e%3c/svg%3e)
Which angels does Rick Klausner often collaborate with?
What are some of recent deals done by Rick Klausner?
Find More Investors Like Rick Klausner
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides
